A platform for CRISPRi-seq in Streptomyces albidoflavus
mBio · 2026
DOI: 10.1128/mbio.03065-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Justin E Clarke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Streptomyces, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Streptomyces produce a multitude of secondary metabolites, which have been exploited in drug discovery campaigns for more than three-quarters of a century. Our understanding of microbial physiology has been revolutionized by genome sequencing and large-scale functional studies. Technology for genome-wide investigations in Streptomyces species, however, has lagged behind that for other bacterial systems, hindering exploitation of unprecedented quantities of genomic data. Here, we develop a platform for en masse clustered regularly interspaced short palindromic repeats interference sequencing (CRISPRi-seq) for Streptomyces spp. By performing CRISPRi-seq with 2,160 unique sgRNAs targeting all operons (432 operons) encoding membrane transporters (629 genes) representing 1.1Mb of the 6.8Mb genome for S. albidoflavus, combined with hit validation, we discovered that only a small proportion (13 of 432 operons, 25 kb) contribute positively to fitness. Our work provides both a first-in-class platform for high-throughput functional genomics and a generalized blueprint for en masse screens in Streptomyces species. IMPORTANCE Streptomyces bacteria are prolific producers of clinically essential natural products, yet high-throughput tools to systematically interrogate their genomes remain underdeveloped. By establishing a robust CRISPRi-seq platform for en masse functional screening in Streptomyces albidoflavus , our work closes a critical technological gap in Streptomyces functional genomics. Our study not only identifies a small subset of transporter operons essential for fitness but also introduces a scalable, generalizable approach for dissecting gene function. This platform will accelerate systems-level understanding of an industrially and medically important genus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
ORCID-Profile: Ryan F Seipke
Förderung
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Clarke, J. E., Faulkner, T. R., & Seipke, R. F. (2026). A platform for CRISPRi-seq in Streptomyces albidoflavus. mBio. https://doi.org/10.1128/mbio.03065-25
Vancouver
Clarke JE, Faulkner TR, Seipke RF. A platform for CRISPRi-seq in Streptomyces albidoflavus. mBio. 2026. doi:10.1128/mbio.03065-25
BibTeX
@article{Clarke2026,
author = {Clarke, Justin E and Faulkner, Tabitha R and Seipke, Ryan F},
title = {A platform for CRISPRi-seq in Streptomyces albidoflavus},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.03065-25}
}
EUVIMED